$484 Million is the total value of SECTOR GAMMA AS's 32 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 16.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMY | Sell | BRISTOL MYERS SQUIBB CO | $37,899,000 | +0.4% | 644,533 | -4.9% | 7.82% | -2.8% |
GILD | Buy | GILEAD SCIENCES INC | $33,375,000 | +123.9% | 433,784 | +117.5% | 6.89% | +116.7% |
MRK | Buy | MERCK & CO INC | $31,055,000 | +8.3% | 401,595 | +7.8% | 6.41% | +4.9% |
INCY | Sell | INCYTE CORP | $28,694,000 | -13.4% | 275,987 | -39.0% | 5.92% | -16.2% |
PKI | Sell | PERKINELMER INC | $25,280,000 | +20.6% | 257,722 | -7.5% | 5.22% | +16.7% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $24,980,000 | -21.2% | 711,482 | -26.7% | 5.16% | -23.7% |
MDT | New | MEDTRONIC PLC | $24,466,000 | – | 266,800 | +100.0% | 5.05% | – |
ABT | Sell | ABBOTT LABS | $23,949,000 | -18.0% | 261,939 | -29.3% | 4.94% | -20.7% |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $19,393,000 | +28.2% | 172,780 | +2.5% | 4.00% | +24.1% |
A | Sell | AGILENT TECHNOLOGIES INC | $18,259,000 | -0.7% | 206,616 | -19.5% | 3.77% | -3.9% |
ANTM | Sell | ANTHEM INC | $18,146,000 | -10.8% | 69,002 | -23.0% | 3.75% | -13.6% |
NUVA | Sell | NUVASIVE INC | $17,345,000 | +8.8% | 311,628 | -1.0% | 3.58% | +5.3% |
BIIB | Sell | BIOGEN INC | $17,182,000 | -27.7% | 64,220 | -14.5% | 3.55% | -30.0% |
PRGO | Sell | PERRIGO CO PLC | $16,061,000 | -6.3% | 290,593 | -18.4% | 3.32% | -9.3% |
HUM | Sell | HUMANA INC | $14,136,000 | +0.8% | 36,457 | -18.4% | 2.92% | -2.4% |
BRKR | Buy | BRUKER CORP | $13,723,000 | +17.1% | 337,346 | +3.2% | 2.83% | +13.4% |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $13,380,000 | +13.4% | 108,482 | -22.3% | 2.76% | +9.8% |
CAH | Buy | CARDINAL HEALTH INC | $12,254,000 | +22.8% | 234,792 | +12.8% | 2.53% | +18.9% |
BIO | Sell | BIO RAD LABS INCcl a | $11,861,000 | +4.2% | 26,270 | -19.1% | 2.45% | +0.9% |
IONS | Sell | IONIS PHARMACEUTICALS INC | $11,201,000 | -14.0% | 189,981 | -31.0% | 2.31% | -16.7% |
PDCO | Sell | PATTERSON COS INC | $10,263,000 | +26.6% | 466,487 | -12.0% | 2.12% | +22.6% |
CVS | Buy | CVS HEALTH CORP | $9,318,000 | +29.9% | 143,416 | +18.7% | 1.92% | +25.8% |
RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $8,505,000 | +31.9% | 108,734 | -25.0% | 1.76% | +27.8% |
DGX | Sell | QUEST DIAGNOSTICS INC | $6,257,000 | -31.1% | 54,906 | -51.4% | 1.29% | -33.2% |
ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $6,174,000 | +4.3% | 41,684 | -23.4% | 1.27% | +1.0% |
CERN | New | CERNER CORP | $5,847,000 | – | 85,300 | +100.0% | 1.21% | – |
ELAN | Sell | ELANCO ANIMAL HEALTH INC | $5,532,000 | -50.8% | 257,891 | -48.6% | 1.14% | -52.3% |
LIVN | Buy | LIVANOVA PLC | $5,251,000 | +62.5% | 109,110 | +52.8% | 1.08% | +57.3% |
PTCT | Buy | PTC THERAPEUTICS INC | $4,587,000 | +35.3% | 90,396 | +18.9% | 0.95% | +31.0% |
JNJ | Sell | JOHNSON & JOHNSON | $4,258,000 | -72.4% | 30,279 | -74.2% | 0.88% | -73.3% |
HCA | New | HCA HEALTHCARE INC | $3,424,000 | – | 35,276 | +100.0% | 0.71% | – |
CLVS | Sell | CLOVIS ONCOLOGY INC | $2,383,000 | -0.4% | 353,085 | -6.1% | 0.49% | -3.5% |
BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -48,490 | -100.0% | -0.48% | – |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -162,554 | -100.0% | -3.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-07
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.